- Home
- FR vs QGEN Comparison
FR vs QGEN Comparison
Compare FR & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FR | QGEN |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.7B |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FR | QGEN |
|---|---|---|
| Price | $62.59 | $42.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $62.17 | $45.76 |
| AVG Volume (30 Days) | 966.0K | ★ 2.5M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | 3.26% | ★ 7.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $727,076,000.00 | N/A |
| Revenue This Year | $11.27 | $8.18 |
| Revenue Next Year | $7.19 | $5.71 |
| P/E Ratio | $37.87 | ★ $24.01 |
| Revenue Growth | ★ 8.58 | N/A |
| 52 Week Low | $48.74 | $32.53 |
| 52 Week High | $69.88 | $57.82 |
Technical Indicators
Market Signals| Indicator | FR | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 35.24 | 59.54 |
| Support Level | $59.98 | $42.82 |
| Resistance Level | $63.89 | $44.22 |
| Average True Range (ATR) | 1.39 | 0.87 |
| MACD | -0.38 | -0.02 |
| Stochastic Oscillator | 0.69 | 58.47 |
Price Performance
Historical ComparisonAbout FR First Industrial Realty Trust Inc.
First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).